These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Trio of studies makes headway in HIV battle. Check E Nature; 2007 Mar; 446(7131):12. PubMed ID: 17330014 [No Abstract] [Full Text] [Related]
9. High frequency of asymptomatic shedding of herpes simplex virus type 2 in African women. Bélec L; Grésenguet G; Mbopi Kéou FX; Mayaud P Clin Microbiol Infect; 2000 Jan; 6(1):56-7. PubMed ID: 11168043 [No Abstract] [Full Text] [Related]
10. Comparison of ovarian follicular activity during treatment with a monthly injectable contraceptive and a low-dose oral contraceptive. Jain JK; Ota F; Mishell DR Contraception; 2000 Mar; 61(3):195-8. PubMed ID: 10827333 [TBL] [Abstract][Full Text] [Related]
11. Effect of contraceptive methods on natural history of HIV: studies from the Mombasa cohort. Baeten JM; Lavreys L; Sagar M; Kreiss JK; Richardson BA; Chohan B; Panteleeff D; Mandaliya K; Ndinya-Achola JO; Overbaugh J; Farley T; Mwachari C; Cohen C; Chipato T; Jaisamrarn U; Kiriwat O; Duerr A J Acquir Immune Defic Syndr; 2005 Mar; 38 Suppl 1():S18-21. PubMed ID: 15867603 [No Abstract] [Full Text] [Related]
12. Treating HIV infection with drugs for HSV-2 infection? Buvé A; Lynen L Lancet; 2010 Mar; 375(9717):782-4. PubMed ID: 20153889 [No Abstract] [Full Text] [Related]
13. Treatment of HIV infection with drugs for HSV-2 infection. Huttner A; Calmy A Lancet; 2010 Jul; 376(9735):88; author reply 88. PubMed ID: 20621229 [No Abstract] [Full Text] [Related]
14. Associations of hormonal contraceptive use with measures of HIV disease progression and antiretroviral therapy effectiveness. Whiteman MK; Jeng G; Samarina A; Akatova N; Martirosyan M; Kissin DM; Curtis KM; Marchbanks PA; Hillis SD; Mandel MG; Jamieson DJ Contraception; 2016 Jan; 93(1):17-24. PubMed ID: 26197261 [TBL] [Abstract][Full Text] [Related]
15. Comparison of cervicovaginal lavage, cervicovaginal lavage enriched with cervical swab, and vaginal tampon for the detection of HIV-1 RNA and HSV-2 DNA in genital secretions. Delany S; Rosas R; Mlaba N; Clayton T; Akpomiemie G; LeGoff J; Capovilla A; Bélec L; Stevens W; Mayaud P J Acquir Immune Defic Syndr; 2008 Dec; 49(4):406-9. PubMed ID: 19186353 [TBL] [Abstract][Full Text] [Related]
16. Herpes Simplex Virus Suppressive Therapy in Herpes Simplex Virus-2/Human Immunodeficiency Virus-1 Coinfected Women Is Associated With Reduced Systemic CXCL10 But Not Genital Cytokines. Andersen-Nissen E; Chang JT; Thomas KK; Adams D; Celum C; Sanchez J; Coombs RW; McElrath MJ; Baeten JM Sex Transm Dis; 2016 Dec; 43(12):761-764. PubMed ID: 27832025 [TBL] [Abstract][Full Text] [Related]
17. No selection of nucleoside reverse transcriptase inhibitor resistance associated mutations by acyclovir suppressive therapy in herpes simplex virus-2/HIV-1 dually infected persons. LeGoff J; Tanton C; Delaugerre C; Weiss HA; Changalucha J; Ross DA; Mugeye K; Belec L; Hayes RJ; Watson-Jones D AIDS; 2010 Oct; 24(16):2595-6. PubMed ID: 20940537 [No Abstract] [Full Text] [Related]